|
市場調査レポート
商品コード
1184255
血管パッチの世界市場規模、シェア、産業動向分析レポート:素材別(生体・合成)、エンドユーザー別(病院・外来手術センター)、用途別、地域別展望・予測、2022年~2028年Global Vascular Patches Market Size, Share & Industry Trends Analysis Report By Material (Biologic and Synthetic), By End User (Hospitals and Ambulatory Surgical Centers), By Application, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
血管パッチの世界市場規模、シェア、産業動向分析レポート:素材別(生体・合成)、エンドユーザー別(病院・外来手術センター)、用途別、地域別展望・予測、2022年~2028年 |
出版日: 2022年12月30日
発行: KBV Research
ページ情報: 英文 209 Pages
納期: 即納可能
|
血管パッチの世界市場規模は、2028年には5億2900万米ドルに達し、予測期間中にCAGR7.1%の市場成長率で上昇すると予測されています。
血管外科手術は、他の臨床分野と多くの特徴があります。血管外科手術のほとんどは清潔ですが、人工グラフトを頻繁に使用するため、一般的に感染の可能性はかなり高くなります。また、血管外科手術を受ける患者は高齢者が多く、糖尿病、免疫系の低下、免疫疾患、高血圧、心臓病など、多くの内科的疾患を抱えている可能性が高くなります。
膵臓や腎臓の移植を行った場合、感染性の血管障害により、移植された臓器だけでなく、移植者の生命や手足が危険にさらされることがあります。このような重篤な血管障害は、複雑な血管修復や血管切除を必要とすることがあります。血管障害の有病率の上昇、老人人口の急増、生物学的パッチの普及、血管手術の増加などが、世界の血管パッチ市場を推進する要因となっています。
COVID-19インパクト分析
患者の病院受診の遅延や緊急医療へのリソースの転用は、COVID-19関連の後遺症に加え、血管手術を受ける患者の健康に大きな影響を与えています。COVID-19手術室規則の適用,個人防護具(PPE)の利用可能性,国の手術基準の遵守に地域差がないにもかかわらず,多くの手術がキャンセルされるか,選択的に延期された.血管外科のサービスと患者へのアクセスは、パンデミックの結果、厳しく制限されています。血管治療は、これまでとはまったく異なる方法で提供されています。外来クリニックや外来診療を行う血管外科医の多くは、遠隔医療サービスの利用や診療時間の短縮など、診療内容が変化したことを報告しています。入院患者サービスに対する影響も同様に大きかっています。
市場の成長要因
老年人口の増加と血管疾患の有病率の上昇
CVD、高血圧、高コレステロール、脳卒中、がん、動脈瘤など、さまざまな疾患や疾病の発生が増加している主な原因の一つは、世界中で高齢者人口が急速に拡大していることにあります。高齢化は心臓の健康状態を低下させる大きな要因であると考えられているため、市場成長の重要な予測因子となっています。2030年には、世界の6人に1人が60歳以上になると、WHOは予測しています。
血管治療の保険償還オプション
血管外科医は、手術中に他の外科専門医をサポートする重要な役割を担っています。この手術支援の頻度や経済的価値は大きく、貢献度や貢献度マージン比率も大きいです。また、血管外科医は顧問医として、極めて複雑な症例を解決することで、病院の経済的価値を大きく高めています。患者さんの第一の特徴は、多疾病であることです。これは、2つ以上の慢性疾患を同時に抱えていることを意味します。
市場の抑制要因
有資格者に対する要求の高まり。
血管パッチは、手術後の動脈の閉鎖が不十分だと出血や虚血が続く可能性があるため、熟練した担当者が取り扱う必要があります。また、ガジェットを使用する際には、多くの操作を順番に行わなければならないです。現在、普及を阻んでいるのは、先進国・新興国ともに外科医が不足していることです。例えば、米国医科大学協会(AAMC)によると、米国では2032年までに12万2,000人の医師が不足すると予想されています。
材料の展望
素材によって、市場は生物学的素材と合成素材に分類されます。2021年の血管パッチの市場シェアは生物学的血管パッチが最も大きく、その主な理由は、適用が容易で、手術後の感染リスクが低く、生体親和性が高いためです。生物学的血管パッチの生分解性品質と、より高い引張強度および縫合糸保持強度は、その主な利点の2つです。
アプリケーションの展望
アプリケーションに基づき、市場は頸動脈内膜切除術、腹部動脈瘤の開腹修復術、血管バイパス手術、先天性心疾患、その他に分類されました。2021年には、頸動脈内膜剥離術が市場で最大の収益シェアを獲得しました。頸動脈の狭窄を緩和し、脳卒中のリスクを下げるために、頸動脈内膜剥離術として知られる手術では、頸動脈を開く必要があります。脳卒中のリスクは、手術の最後に動脈を閉じる際に、動脈の開口部にパッチを貼ることで軽減されます。
エンドユーザー向け展望
エンドユーザーに基づき、市場は病院と外来手術センターに分類されます。外来手術センターは、予測期間中に最も速い成長を遂げると予想されます。外来手術センター協会によると、外来手術センター(ASC)は、診断および予防処置を含む同日手術治療を提供するために設計された全く新しいタイプの医療機関です。
地域別展望
地域別に見ると、北米、欧州、アジア太平洋、LAMEAに分類されます。同地域では高齢者人口の増加や心血管疾患の有病率が高いことから、北米は血管パッチの世界市場において主導的な地位を占めると予測されます。例えば、米国国勢調査局の2015年3月の記事によると、同国の高齢者人口は2014年の3億1900万人から2060年には4億人以上に増加し、2051年には4億人に達すると予測されています。
List of Figures
The Global Vascular Patches Market size is expected to reach $529 Million by 2028, rising at a market growth of 7.1% CAGR during the forecast period.
Vascular patches are microporous polyester-urethane patches used in vascular procedures to close the wound with sutures. The World Health Organization (WHO) reports that cardiovascular diseases-which take 17.9 million lives annually-are the main cause of death. Vascular patches have great tissue integration, are highly biocompatible, have low infectious potential, low suture line bleeding, don't require impregnation or pre-clotting, and have good handling characteristics.
Due to the growing frequency of cardiac difficulties, technological advancements, and improvements in healthcare, the global market for vascular patches is anticipated to develop profitably in the years to come. A recent cross-disciplinary area of medical study is vascular surgery. Vascular surgeries are classed in that a range of artificial grafts (stents, stent-grafts, artificial blood vessels) are commonly used in clinical disciplines.
Vascular surgeries have many features with other clinical disciplines. Although most vascular surgical procedures are clean, the likelihood of infection is typically substantial since artificial grafts are frequently used. Additionally, patients undergoing vascular surgery are frequently elderly and are more likely to have a number of internal medical conditions, including diabetes, weak immune systems, immunological disorders, hypertension, and heart disease.
After pancreas or kidney transplantation, infectious vascular problems can put the recipient's life and limb, as well as the donated organ, in danger. These serious disorders can call for intricate vascular repair and vascular excision. The prevalence of vascular disorders is rising, the geriatric population is expanding quickly, biological patches are being more widely used, and there are more vascular surgeries being conducted, all of which are factors that are propelling the worldwide vascular patches market.
COVID-19 Impact Analysis
Patients delaying hospital exposure and diverting resources to urgent care have had a significant impact on the health of patients undergoing vascular surgery, in addition to COVID-19-related aftereffects. Despite no regional variation in the application of COVID-19 operating room rules, accessibility to personal protective equipment (PPE), or compliance with national surgical standards, many surgeries were either canceled or postponed electively. Vascular surgery services and patient access have been severely limited as a result of the pandemic. Vascular care is being delivered in a very different way. Many vascular surgeons who practice in outpatient clinics and ambulatory care reported that their practice has altered, including the use of telemedicine services and shorter hours. The impact on inpatient services was likewise significant.
Market Growth Factors
Increasing Geriatric Population And Rising Vascular Disease Prevalence
One of the main causes of the rising occurrence of various diseases and ailments, including CVDs, hypertension, high cholesterol, strokes, cancer, and aneurysms, is the rapidly expanding senior population worldwide. The aging population is a key predictor of market growth because it is thought that aging is a major factor in the decline of cardiac health. By 2030, one in every six people worldwide will be 60 years of age or older, predicts the WHO.
Reimbursement Options For Vascular Treatments
Vascular surgeons support other surgical specialties during operations in a crucial way. The frequency and financial worth of this operational support, which has a large contribution margin and contribution margin ratio, are substantial. Vascular surgeons, in their function as consulting surgeons, facilitate the resolution of extremely complex cases and, in doing so, add significantly to the hospital's financial value. The primary characteristic of patients is multi-morbidity. It denotes the concurrent presence of two or more chronic diseases.
Market Restraining Factors
Growing requirement for qualified personnel.
Vascular patches must be handled by skilled personnel since poor artery closure following surgery can result in ongoing bleeding or ischemia. While using some gadgets, many actions must be taken in order. One of the main barriers preventing the widespread use of these goods at the moment is the shortage of surgeons in both industrialized and emerging nations. For instance, the US is expected to experience a 122,000 physician deficit by 2032, according to the Association of American Medical Colleges (AAMC).
Material Outlook
Based on material, the market is classified into biologic and synthetic. The biologic vascular patch segment held the largest market share for vascular patches in 2021, mainly because it was easier to apply, had a lower risk of infection after surgery, and had greater biocompatibility. The biologic vascular patches' biodegradable quality and greater tensile and suture retention strength are two of their key advantages.
Application Outlook
Based on Applications, the market was categorized into Carotid Endarterectomy, Open Repair of Abdominal Aneurysm, Vascular Bypass Surgery, Congenital Heart Diseases, and Others. During 2021, carotid endarterectomy gained the largest revenue share in the market. In order to relieve this narrowing and so lower the risk of stroke, a procedure known as a carotid endarterectomy requires opening the carotid artery. The risk of strokes is decreased by placing a patch into the opening in the artery as the artery is closed at the end of the procedure.
End-user Outlook
Based on the End-user, the market is categorized into Hospitals and Ambulatory Surgical Centers. Ambulatory surgery centers are anticipated to experience the fastest growth during the forecasted timeframe. According to the ambulatory surgical center association, ambulatory surgery centers (ASCs) are a brand-new type of healthcare institution designed to provide same-day surgical treatment, including diagnostic and preventative procedures.
Regional Outlook
Based on geography, the market is classified into North America, Europe, Asia Pacific, and LAMEA. Due to the rising elderly population and the high prevalence of cardiovascular illnesses in the region, North America is predicted to have a leading position in the global market for vascular patches. For instance, a March 2015 article from the US Census Bureau states that the country's elderly population is projected to rise from 319 million in 2014 to more than 400 million in 2060, hitting 400 million in 2051.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
Strategies Deployed in Vascular Patches Market
Sep-2022: Edwards Lifesciences released the SAPIEN 3 Ultra RESILIA valve, a catheter-based artificial heart valve system consisting of RESILIA tissue technology. This launch shows the Company's effort in innovations to address the present and future requirements of patients to help them live healthier, longer, and more productive.
Sep-2022: W. L. Gore & Associates took over InnAVasc Medical, a small medical technology company. Through this acquisition, W. L. Gore & Associates would add InnAVasc's investigational technology to strengthen the company's plan to enhance patients' lives by delivering physicians-developed treatment solutions in dialysis access space.
Dec-2021: Becton, Dickinson, and Company completed the acquisition of Venclose, Inc., a medical technology company. Under this acquisition, Becton, Dickinson, and Company would broaden developments in the treatment of Chronic Venous Disease. Additionally, the acquisition would allow the company to offer a strong suite of solutions to physicians treating the complete extent of venous conditions.
Dec-2021: Baxter International Inc. completed the acquisition of Hillrom, a provider of medical technology. This acquisition would help Baxter in reaching another level of transformation, offering a new wave of ability to deliver better results for employees, shareholders, patients, and other parties whom the company serves globally.
Jan-2020: Terumo released New Surgical Sealant AQUABRID®, a new surgical sealant developed for aortic procedures, across the EMEA market. The product would deliver a new market for the business in a segment of growing importance for its business.
Oct-2019: LeMaitre Vascular, Inc. took over the biologic patch business of Admedus Ltd., a structural heart company engaged in offering clinically advanced solutions. The patches taken over by LeMaitre Vascular, Inc. are marketed under the brands VascuCel and CardioCel and are designed in a way to decrease the risk of calcification.
Apr-2019: Edwards Lifesciences Corporation took over CAS Medical Systems, Inc., a medical technology engaged in the monitoring of non-invasive brain and tissue oxygenation. Under This acquisition, Edwards would combine HemoSphere's advanced hemodynamic monitoring platform with FORE-SIGHT technology to build a specific suite of better recovery tools and abilities of predictive analytics for clinicians.
Oct-2018: LeMaitre Vascular Inc. acquired Cardial, a subsidiary of Becton, Dickinson & Company, a medical technology company. Under this acquisition, LeMaitre Vascular Inc. would broaden its global presence in the area of supporting vascular surgeons.
Market Segments covered in the Report:
By Material
By End User
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research